Cargando…

Tolcapone Potently Inhibits Seminal Amyloid Fibrils Formation and Blocks Entry of Ebola Pseudoviruses

Ebola virus (EBOV), the causative pathogen of the deadly EBOV disease (EVD), can be transmitted via sexual transmission. Seminal amyloid fibrils have been found enhancers of EBOV infection. Currently, limited preventive vaccine or therapeutic is available to block EBOV infection through sexual inter...

Descripción completa

Detalles Bibliográficos
Autores principales:	Qiu, Mengjie, Li, Zhaofeng, Chen, Yuliu, Guo, Jiayin, Xu, Wei, Qi, Tao, Qiu, Yurong, Pang, Jianxin, Li, Lin, Liu, Shuwen, Tan, Suiyi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203225/ https://www.ncbi.nlm.nih.gov/pubmed/32425892 http://dx.doi.org/10.3389/fmicb.2020.00504

Ejemplares similares

Sertraline Is an Effective SARS-CoV-2 Entry Inhibitor Targeting the Spike Protein
por: Chen, Yuliu, et al.
Publicado: (2022)

Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
por: Sant'Anna, Ricardo, et al.
Publicado: (2016)

Teicoplanin inhibits Ebola pseudovirus infection in cell culture
por: Wang, Yizhuo, et al.
Publicado: (2016)

A Novel CXCR4 Targeting Protein SDF-1/54 as an HIV-1 Entry Inhibitor
por: Tan, Suiyi, et al.
Publicado: (2019)

Utility of tolcapone in fluctuating Parkinson’s disease
por: Stocchi, Fabrizio, et al.
Publicado: (2006)

Author Correction: Repositioning tolcapone as a potent inhibitor of transthyretin amyloidogenesis and associated cellular toxicity
por: Sant’Anna, Ricardo, et al.
Publicado: (2023)

Effects of tolcapone and bromocriptine on cognitive stability and flexibility
por: Cameron, Ian G. M., et al.
Publicado: (2018)

Formulation of Sustained Release Hydrophilic Matrix Tablets of Tolcapone with the Application of Sedem Diagram: Influence of Tolcapone’s Particle Size on Sustained Release
por: Nardi-Ricart, Anna, et al.
Publicado: (2020)

The efficacy of homemade tolcapone in the treatment of patients with Parkinsons disease
por: Zhang, Pei-Lan, et al.
Publicado: (2018)

Safety and efficacy of tolcapone in Parkinson’s disease: systematic review
por: Artusi, Carlo Alberto, et al.
Publicado: (2021)

Micro- and Nano-Systems Developed for Tolcapone in Parkinson’s Disease
por: Casanova, Yaquelyn, et al.
Publicado: (2022)

Suramin is a potent inhibitor of Chikungunya and Ebola virus cell entry
por: Henß, Lisa, et al.
Publicado: (2016)

Inhibition of SARS Pseudovirus Cell Entry by Lactoferrin Binding to Heparan Sulfate Proteoglycans
por: Lang, Jianshe, et al.
Publicado: (2011)

Tolcapone-Enhanced Neurocognition in Healthy Adults: Neural Basis and Predictors
por: Bhakta, Savita G, et al.
Publicado: (2017)

Establishment of pseudovirus infection mouse models for in vivo pharmacodynamics evaluation of filovirus entry inhibitors
por: Chen, Qing, et al.
Publicado: (2018)

An optimized and robust SARS-CoV-2 pseudovirus system for viral entry research
por: Yang, Peng, et al.
Publicado: (2021)

Screening and identification of HTNV(pv) entry inhibitors with high-throughput pseudovirus-based chemiluminescence
por: Wen, Xiaojing, et al.
Publicado: (2022)

N′-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile
por: Garcia-Rubia, Alfonso, et al.
Publicado: (2023)

A Pseudovirus-Based Entry Assay to Evaluate Neutralizing Activity against Respiratory Syncytial Virus
por: Hu, Longbo, et al.
Publicado: (2023)

Sulfonated Compounds Bind with Prostatic Acid Phosphatase (PAP(248–286)) to Inhibit the Formation of Amyloid Fibrils
por: Zhang, Tingting, et al.
Publicado: (2018)

Tolcapone: review of its pharmacology and use as adjunctive therapy in patients with Parkinson’s disease
por: Truong, Daniel D
Publicado: (2009)

Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma
por: Maser, Tyler, et al.
Publicado: (2017)

Polyanionic Candidate Microbicides Accelerate the Formation of Semen-Derived Amyloid Fibrils to Enhance HIV-1 Infection
por: Tan, Suiyi, et al.
Publicado: (2013)

Development of cell-based pseudovirus entry assay to identify potential viral entry inhibitors and neutralizing antibodies against SARS-CoV-2
por: Hu, Jie, et al.
Publicado: (2020)

Right inferior frontal cortex activity correlates with tolcapone responsivity in problem and pathological gamblers
por: Kayser, Andrew S., et al.
Publicado: (2016)

Addition of Tolcapone in Intrajejunal Levodopa Infusion Therapy Requires a Pronounced Dose Reduction
por: Schröter, Nils, et al.
Publicado: (2020)

Analysis of Ebola Virus Entry Into Macrophages
por: Dahlmann, Franziska, et al.
Publicado: (2015)

Catechol-o-methyltransferase inhibitor tolcapone improves learning and memory in naïve but not in haloperidol challenged rats
por: Mihaylova, Anita, et al.
Publicado: (2019)

Tolcapone in Obsessive Compulsive disorder: A Randomized Double-Blind Placebo-Controlled Crossover Trial
por: Grant, Jon E., et al.
Publicado: (2021)

Pseudoviruses for the assessment of coronavirus disinfection by ozone
por: Zucker, Ines, et al.
Publicado: (2021)

IgY antibodies against Ebola virus possess post-exposure protection in a murine pseudovirus challenge model and excellent thermostability
por: Zhang, Yuan, et al.
Publicado: (2021)

Potent neutralizing monoclonal antibodies against Ebola virus infection
por: Zhang, Qi, et al.
Publicado: (2016)

Polygoni multiflori radix extracts inhibit SARS-CoV-2 pseudovirus entry in HEK293T cells and zebrafish larvae
por: Wang, Xiaoyang, et al.
Publicado: (2022)

Neuromasts and Olfactory Organs of Zebrafish Larvae Represent Possible Sites of SARS-CoV-2 Pseudovirus Host Cell Entry
por: Choi, Sheyne S. A., et al.
Publicado: (2022)

COMT inhibition with tolcapone in the treatment algorithm of patients with Parkinson’s disease (PD): relevance for motor and non-motor features
por: Antonini, Angelo, et al.
Publicado: (2008)

Elucidating Differences in the Hepatotoxic Potential of Tolcapone and Entacapone With DILIsym(®), a Mechanistic Model of Drug‐Induced Liver Injury
por: Longo, DM, et al.
Publicado: (2016)

Tolcapone improves outcomes in patients with Parkinson disease treated by levodopa/carbidopa intestinal gel: A pilot study
por: Valkovič, Peter, et al.
Publicado: (2022)

A molecular tweezer antagonizes seminal amyloids and HIV infection
por: Lump, Edina, et al.
Publicado: (2015)

SARS-CoV-2 Spike Pseudoviruses: A Useful Tool to Study Virus Entry and Address Emerging Neutralization Escape Phenotypes
por: Kalkeri, Raj, et al.
Publicado: (2021)

Chemical and Structural Aspects of Ebola Virus Entry Inhibitors
por: Nyakatura, Elisabeth K., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_75pbll7bifmvg8tikjgf0k2765